data/documents.csv

filename,description,mrn,note
"progress_note_1.txt","Primary Care Follow-up Visit","MRN12345678","Patient is a 57-year-old male with history of hypertension, type 2 diabetes, and hyperlipidemia presenting for routine follow-up. BP today is 138/82, weight stable at 87kg. A1c improved from 7.8 to 7.2. Patient reports good medication adherence and states he is walking 30 minutes daily. Physical exam unremarkable. Assessment: 1) Hypertension - well controlled, continue current regimen 2) T2DM - improving, continue metformin 1000mg BID 3) Hyperlipidemia - LDL at goal, continue atorvastatin. Plan: Continue current medications, follow-up in 3 months, routine labs before next visit."
"ed_visit_note.txt","Emergency Department Visit for Chest Pain","MRN87654321","45-year-old female with no significant past medical history presents with sudden onset substernal chest pain that started 2 hours ago while at rest. Pain is 7/10, described as pressure-like, radiating to left arm, associated with mild SOB and nausea. Vitals: T 37.0, HR 102, BP 142/88, RR 18, SpO2 98% on RA. EKG shows NSR without ST changes. Initial troponin negative. CXR without acute findings. Patient given aspirin 325mg, sublingual nitroglycerin with relief of symptoms. Assessment: Acute chest pain, unclear etiology, low-intermediate risk for ACS. Plan: Admit to observation unit for serial troponins and stress test in AM."
"discharge_summary.txt","Hospital Discharge Summary - Pneumonia","MRN23456789","72-year-old male with COPD admitted for community-acquired pneumonia. Patient presented with 4 days of productive cough, fever, and worsening shortness of breath. CXR showed RLL infiltrate. Treated with IV ceftriaxone and azithromycin for 3 days with clinical improvement, then transitioned to oral antibiotics. O2 requirements decreased from 4L to baseline 2L. Pulmonary function optimized with scheduled bronchodilators. Discharged home on 7-day course of amoxicillin-clavulanate with pulmonology follow-up in 2 weeks. Patient educated on importance of pneumococcal and influenza vaccinations. Follow-up CXR recommended in 6 weeks to ensure resolution."